Can I run two of them together?
Answer
Approved labeling in this class warns against using two GLP-1 receptor agonists at the same time.
In more detail
The labels are explicit about not combining products in this class, and the reason is straightforward: the effects add on the same receptor, and so do the gut effects. Amylin analogues like cagrilintide sit on a different pathway, which is why they come up as an add-on rather than a replacement — but that combination has published trial data behind it and no approved label, so it is a study design rather than a schedule.
Source
Approved labeling for the weekly incretin products.
Educational use only, never medical advice. No doses.